TODD STRATEGY GROUP

Lobbying for INSULET CORPORATION · Medical device manufacturing, innovative medical technologies.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

General education on diabetes care. General education about Insulet.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.